Ligand Pharmaceuticals | LGND - Interest Expense On Debt

Ligand Pharmaceuticals reported $332K in Interest Expense on Debt for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Interest Expense On Debt Change
Agenus AGEN:US USD 17.32M 1.72M
Amgen AMGN:US USD 415M 47M
Baxter International BAX:US USD 125M 16M
Bristol Myers Squibb BMY:US USD 294M 5M
Clovis Oncology CLVS:US USD 9.86M 189K
Endo International Ordinary Shares ENDP:US USD 74.93M 65M
Gilead Sciences GILD:US USD 227M 2M
Harsco HSC:US USD 23.62M 3.87M
Immunogen IMGN:US USD 971K 104K
Insmed INSM:US USD 16.44M 13.09M
Intrexon XON:US USD 637K 1.4M
IONIS PHARMACEUT IONS:US USD 1.73M 408K
Karyopharm Therapeutics KPTI:US USD 5.88M 229K
Pacira Pharmaceuticals PCRX:US USD 11.04M 1.18M
Pfizer PFE:US USD 313M 2M
Spectrum Pharmaceuticals SPPI:US 901K 801K
Teva Pharmaceutical Industries TEVA:US USD 237M 7M
Veracyte VCYT:US USD 5K 56K